Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytomX Therapeutics, Inc. | 38,224 | reported | 16 Mar 2023 | tx 11+698,921−5,697 |
| Zymeworks Inc. | 11,500 | reported | 12 Jan 2026 | tx 5+137,200 |
| ALDER BIOPHARMACEUTICALS INC | 0 | reported | 22 Oct 2019 | tx 2+270,000−270,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jan 2026 | GRANT_AWARD | Zymeworks Inc. | 11,500 | 0.00 USD | deriv |
| 12 Jan 2026 | GRANT_AWARD | Zymeworks Inc. | 7,700 | 0.00 USD | deriv |
| 10 Dec 2024 | GRANT_AWARD | Zymeworks Inc. | 31,000 | 0.00 USD | deriv |
| 07 Dec 2023 | GRANT_AWARD | Zymeworks Inc. | 37,000 | 0.00 USD | deriv |
| 30 Jun 2023 | GRANT_AWARD | Zymeworks Inc. | 50,000 | 0.00 USD | deriv |
| 16 Mar 2023 | SALE | CytomX Therapeutics, Inc. | 1,748 | 1.98 USD | |
| 19 Jul 2022 | GRANT_AWARD | CytomX Therapeutics, Inc. | 15,000 | 0.00 USD | |
| 20 Jul 2022 | SALE | CytomX Therapeutics, Inc. | 3,949 | 1.42 USD | |
| 02 Feb 2022 | GRANT_AWARD | CytomX Therapeutics, Inc. | 22,500 | 0.00 USD | |
| 02 Feb 2022 | GRANT_AWARD | CytomX Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |
| 24 Oct 2021 | GRANT_AWARD | CytomX Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 24 Oct 2021 | GRANT_AWARD | CytomX Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 31 May 2021 | GRANT_AWARD | CytomX Therapeutics, Inc. | 3,320 | 6.09 USD | |
| 26 Feb 2021 | GRANT_AWARD | CytomX Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 30 Nov 2020 | GRANT_AWARD | CytomX Therapeutics, Inc. | 3,101 | 6.39 USD | |
| 23 Mar 2020 | GRANT_AWARD | CytomX Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 22 Oct 2019 | OTHER | ALDER BIOPHARMACEUTICALS INC | 270,000 | 0.00 USD | deriv |
| 12 Dec 2018 | GRANT_AWARD | ALDER BIOPHARMACEUTICALS INC | 270,000 | 0.00 USD | deriv |